echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > It is expected to usher in a special medicine to stay away from uremia!

    It is expected to usher in a special medicine to stay away from uremia!

    • Last Update: 2021-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The development of the Great Wall Cardiology Conference is a magnificent history of struggle passed down from generation to generation


    Hu Dayi

    This year is the 32nd Great Wall Cardiology Conference.


    On the afternoon of October 28th, Professor Liu Tong from Beijing Anzhen Hospital Affiliated to Capital Medical University brought a topic worthy of attention-"The Cardio and Kidney Protective Effect of Finnelrone "


    The cardio-renal protective effect of fennelrone, Professor Liu Tong from Beijing Anzhen Hospital, Capital Medical University

    2021 Great Wall Meeting, (right) Professor Liu Tong

    2021 Great Wall Meeting, (right) Professor Liu Tong

    Professor Liu Tong believes that our heart vascular disease burden heavy proteinuria is an independent predictor of cardiovascular (CV) risk, proteinuria increased warning endothelial damage and high risk for cardiovascular disease already exists, the early detection of urinary protein is a blood vessel An important indicator for endothelial injury and CVD risk screening


    Heart blood vessels albuminuria is an independent predictor of cardiovascular (CV) risk, proteinuria increased warning endothelial damage and high risk for cardiovascular disease already exists, the early detection of urinary protein vascular endothelial injury and CVD risk screening important indicator of


    In cardiovascular patients, the risk of CV in patients with type 2 diabetes increases by 2 to 4 times.


    In cardiovascular patients, the risk of CV in patients with type 2 diabetes increases by 2 to 4 times.


     

    So, why is the risk of CV significantly increased in patients with proteinuria?

    Professor Liu Tong explained that the production of proteinuria means that the filtration barrier is damaged and the vascular endothelium is damaged


    Metabolic syndrome

    The excessive activation of mineralocorticoid receptor (MR) is an important mechanism leading to cardiovascular endothelial function damage and cardiovascular events


    Cardiovascular events inhibiting the excessive activation of MR are essential for inhibiting vascular endothelial damage, reducing the risk of CV, and delaying CVD


    Inflammation and fibrosis extensively affect the kidneys, blood vessels and heart, leading to glomerulus, renal tubular damage, proteinuria, renal blood flow changes and kidney damage, leading to vascular damage such as vascular remodeling, endothelial dysfunction, and hardening of blood vessel walls; At the same time, it can also cause cardiac damage such as myocardial hypertrophy, ventricular remodeling, reduced coronary blood flow, myocardial ischemia/infarction, and myocardial injury


    Professor Liu Tong explained a FIGARO study, which is a global, multi-center, large-scale phase III clinical study of Finerenone in type 2 diabetic patients with nephropathy.


    In patients with type 2 diabetes and nephropathy, on the basis of giving good blood pressure and blood sugar control, and maximizing RASI treatment, the use of Finerenone significantly reduces cardiovascular composite end points (cardiovascular death, non-fatal myocardial infarction , non -fatal myocardial infarction) .


    All in all, the new generation of Fez-based MAR-Finerenone can effectively and accurately inhibit MR, bringing full benefits to the heart and kidneys


    The new generation of Fez-based MAR-Finerenone can effectively and accurately inhibit MR, bringing full benefit to the heart and kidneys




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.